申请人:The Regents of the University of California
                            
                            
                                公开号:US20160168151A1
                            
                            
                                公开(公告)日:2016-06-16
                            
                            This invention generally relates to pyrazolo pyrimidine derivatives useful as, inter alia, inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. More specifically, the invention relates to pyrazolo pyrimidine derivatives, including derivatives and analogs of SDR inhibitors, pharmaceutical compositions containing derivatives and analogs of SDR inhibitors, methods of making derivatives and analogs of SDR inhibitors and methods of use thereof.
                            本发明通常涉及作为短链脱氢酶/还原酶(
SDR)家族
NAD(P)(H)依赖性氧化还原酶的
抑制剂的
吡唑嘧啶衍
生物。更具体地,本发明涉及
吡唑嘧啶衍
生物,包括
SDR
抑制剂的衍
生物和类似物,含有
SDR
抑制剂的衍
生物和类似物的制药组合物,制备
SDR
抑制剂的衍
生物和类似物的方法以及其使用方法。